HomeinvestmentGSK plans $30 billion US investment as pharma tariff threat looms

GSK plans $30 billion US investment as pharma tariff threat looms

The company said its new facilities will

web-interns@dakdan.com

RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments